Alkeon Capital Management
BPMC

Alkeon Capital Management’s Blueprint Medicines BPMC Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-900,628
Closed -$79.7M 85
2025
Q1
$79.7M Buy
900,628
+100,000
+12% +$8.85M 0.17% 44
2024
Q4
$69.8M Buy
800,628
+81,700
+11% +$7.13M 0.14% 46
2024
Q3
$66.5M Sell
718,928
-175,000
-20% -$16.2M 0.11% 49
2024
Q2
$96.3M Buy
893,928
+100,000
+13% +$10.8M 0.16% 45
2024
Q1
$75.3M Buy
793,928
+150,000
+23% +$14.2M 0.13% 50
2023
Q4
$59.4M Sell
643,928
-300,000
-32% -$27.7M 0.13% 53
2023
Q3
$47.4M Hold
943,928
0.08% 61
2023
Q2
$59.7M Buy
943,928
+591,745
+168% +$37.4M 0.1% 57
2023
Q1
$15.8M Sell
352,183
-74,085
-17% -$3.33M 0.03% 77
2022
Q4
$18.7M Sell
426,268
-693,144
-62% -$30.4M 0.07% 82
2022
Q3
$73.8M Buy
1,119,412
+44,512
+4% +$2.93M 0.24% 56
2022
Q2
$54.3M Sell
1,074,900
-68,999
-6% -$3.49M 0.15% 72
2022
Q1
$73.1M Sell
1,143,899
-128,601
-10% -$8.22M 0.15% 76
2021
Q4
$136M Hold
1,272,500
0.25% 67
2021
Q3
$131M Buy
1,272,500
+200,000
+19% +$20.6M 0.22% 73
2021
Q2
$94.3M Buy
1,072,500
+100,000
+10% +$8.8M 0.14% 79
2021
Q1
$94.6M Buy
972,500
+75,000
+8% +$7.29M 0.14% 79
2020
Q4
$101M Hold
897,500
0.16% 71
2020
Q3
$83.2M Buy
897,500
+185,000
+26% +$17.1M 0.15% 73
2020
Q2
$55.6M Sell
712,500
-400,000
-36% -$31.2M 0.14% 78
2020
Q1
$65.1M Buy
1,112,500
+775,000
+230% +$45.3M 0.28% 55
2019
Q4
$27M Buy
337,500
+150,000
+80% +$12M 0.1% 70
2019
Q3
$13.8M Buy
187,500
+62,500
+50% +$4.59M 0.05% 83
2019
Q2
$11.8M Hold
125,000
0.05% 89
2019
Q1
$10M Sell
125,000
-99,346
-44% -$7.95M 0.05% 82
2018
Q4
$12.1M Buy
+224,346
New +$12.1M 0.08% 76
2018
Q3
Sell
-245,075
Closed -$15.6M 95
2018
Q2
$15.6M Buy
245,075
+133,500
+120% +$8.47M 0.07% 71
2018
Q1
$10.2M Buy
111,575
+101,575
+1,016% +$9.31M 0.05% 71
2017
Q4
$754K Buy
+10,000
New +$754K ﹤0.01% 59